Steve Beuchaw
Stock Analyst at Morgan Stanley
(2.37)
# 2,546
Out of 5,138 analysts
98
Total ratings
58.46%
Success rate
6.33%
Average return
Main Sectors:
Stocks Rated by Steve Beuchaw
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| QGEN Qiagen | Downgrades: Equal-Weight | $49 → $47 | $55.45 | -15.08% | 2 | Jan 6, 2025 | |
| A Agilent Technologies | Initiates: Outperform | n/a | $135.83 | - | 20 | Dec 13, 2023 | |
| ALGN Align Technology | Maintains: Outperform | $711 → $770 | $165.55 | +365.12% | 11 | Jul 29, 2021 | |
| BRKR Bruker | Upgrades: Peer Perform | n/a | $49.84 | - | 9 | Nov 16, 2020 | |
| HSIC Henry Schein | Upgrades: Outperform | $68 | $77.73 | -12.52% | 4 | Apr 2, 2020 | |
| XRAY DENTSPLY SIRONA | Upgrades: Outperform | $66 | $12.05 | +447.72% | 6 | Apr 2, 2020 | |
| ILMN Illumina | Maintains: Equal-Weight | $320 → $288 | $147.17 | +95.69% | 9 | Jan 7, 2019 | |
| TMO Thermo Fisher Scientific | Maintains: Overweight | $254 → $260 | $619.01 | -58.00% | 7 | Oct 25, 2018 | |
| WAT Waters | Maintains: Equal-Weight | $204 → $211 | $383.86 | -45.03% | 13 | Oct 10, 2018 | |
| MYGN Myriad Genetics | Maintains: Overweight | $51 → $54 | $5.68 | +850.70% | 10 | Oct 10, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $21 → $41 | $234.85 | -82.54% | 5 | Sep 28, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Equal-Weight | $335 | $312.76 | +7.11% | 1 | Sep 20, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Equal-Weight | $335 | $312.75 | +7.11% | 1 | Sep 20, 2018 |
Qiagen
Jan 6, 2025
Downgrades: Equal-Weight
Price Target: $49 → $47
Current: $55.45
Upside: -15.08%
Agilent Technologies
Dec 13, 2023
Initiates: Outperform
Price Target: n/a
Current: $135.83
Upside: -
Align Technology
Jul 29, 2021
Maintains: Outperform
Price Target: $711 → $770
Current: $165.55
Upside: +365.12%
Bruker
Nov 16, 2020
Upgrades: Peer Perform
Price Target: n/a
Current: $49.84
Upside: -
Henry Schein
Apr 2, 2020
Upgrades: Outperform
Price Target: $68
Current: $77.73
Upside: -12.52%
DENTSPLY SIRONA
Apr 2, 2020
Upgrades: Outperform
Price Target: $66
Current: $12.05
Upside: +447.72%
Illumina
Jan 7, 2019
Maintains: Equal-Weight
Price Target: $320 → $288
Current: $147.17
Upside: +95.69%
Thermo Fisher Scientific
Oct 25, 2018
Maintains: Overweight
Price Target: $254 → $260
Current: $619.01
Upside: -58.00%
Waters
Oct 10, 2018
Maintains: Equal-Weight
Price Target: $204 → $211
Current: $383.86
Upside: -45.03%
Myriad Genetics
Oct 10, 2018
Maintains: Overweight
Price Target: $51 → $54
Current: $5.68
Upside: +850.70%
Sep 28, 2018
Maintains: Overweight
Price Target: $21 → $41
Current: $234.85
Upside: -82.54%
Sep 20, 2018
Initiates: Equal-Weight
Price Target: $335
Current: $312.76
Upside: +7.11%
Sep 20, 2018
Initiates: Equal-Weight
Price Target: $335
Current: $312.75
Upside: +7.11%